Morizane C - Search Results

1

C-Reactive Protein Level Is an Indicator of the Aggressiveness of Advanced Pancreatic Cancer.

Mitsunaga S, Ikeda M, Shimizu S, Ohno I, Takahashi H, Okuyama H, Ueno H, Morizane C, Kondo S, Sakamoto Y, Okusaka T, Ochiai A. Mitsunaga S, et al. Among authors: morizane c. Pancreas. 2016 Jan;45(1):110-6. doi: 10.1097/MPA.0000000000000465. Pancreas. 2016. PMID: 26566216

2

Phase II study of cisplatin, epirubicin, and continuous-infusion 5-fluorouracil for advanced biliary tract cancer.

Morizane C, Okada S, Okusaka T, Ueno H, Saisho T. Morizane C, et al. Oncology. 2003;64(4):475-6. doi: 10.1159/000070310. Oncology. 2003. PMID: 12759549 Clinical Trial. No abstract available.

3

Phase II study of radiotherapy combined with gemcitabine for locally advanced pancreatic cancer.

Okusaka T, Ito Y, Ueno H, Ikeda M, Takezako Y, Morizane C, Kagami Y, Ikeda H. Okusaka T, et al. Among authors: morizane c. Br J Cancer. 2004 Aug 16;91(4):673-7. doi: 10.1038/sj.bjc.6602001. Br J Cancer. 2004. PMID: 15226765 Free PMC article. Clinical Trial.

4

[Tumor markers for pancreatic and biliary tract cancer].

Takezako Y, Okusaka T, Ueno H, Ikeda M, Morizane C, Najima M. Takezako Y, et al. Among authors: morizane c. Gan To Kagaku Ryoho. 2004 Sep;31(9):1443-6. Gan To Kagaku Ryoho. 2004. PMID: 15446574 Review. Japanese.

5

Phase II study of S-1 in patients with advanced biliary tract cancer.

Ueno H, Okusaka T, Ikeda M, Takezako Y, Morizane C. Ueno H, et al. Among authors: morizane c. Br J Cancer. 2004 Nov 15;91(10):1769-74. doi: 10.1038/sj.bjc.6602208. Br J Cancer. 2004. PMID: 15505626 Free PMC article. Clinical Trial.

6

A phase II trial of continuous infusion of 5-fluorouracil, mitoxantrone, and cisplatin for metastatic hepatocellular carcinoma.

Ikeda M, Okusaka T, Ueno H, Takezako Y, Morizane C. Ikeda M, et al. Among authors: morizane c. Cancer. 2005 Feb 15;103(4):756-62. doi: 10.1002/cncr.20841. Cancer. 2005. PMID: 15637692 Free article. Clinical Trial.

7

An early phase II study of S-1 in patients with metastatic pancreatic cancer.

Ueno H, Okusaka T, Ikeda M, Takezako Y, Morizane C. Ueno H, et al. Among authors: morizane c. Oncology. 2005;68(2-3):171-8. doi: 10.1159/000086771. Epub 2005 Jul 4. Oncology. 2005. PMID: 16006754 Clinical Trial.

8

Chemoradiotherapy for locally advanced pancreatic carcinoma in elderly patients.

Morizane C, Okusaka T, Ito Y, Ueno H, Ikeda M, Takezako Y, Kagami Y, Ikeda H. Morizane C, et al. Oncology. 2005;68(4-6):432-7. doi: 10.1159/000086985. Epub 2005 Jul 14. Oncology. 2005. PMID: 16020973

9

A phase II trial of Uracil-tegafur (UFT) in patients with advanced biliary tract carcinoma.

Ikeda M, Okusaka T, Ueno H, Morizane C, Furuse J, Ishii H. Ikeda M, et al. Among authors: morizane c. Jpn J Clin Oncol. 2005 Aug;35(8):439-43. doi: 10.1093/jjco/hyi131. Epub 2005 Jul 15. Jpn J Clin Oncol. 2005. PMID: 16024530 Clinical Trial.

10

Phase I study of fixed dose rate infusion of gemcitabine in patients with unresectable pancreatic cancer.

Furuse J, Ishii H, Okusaka T, Nagase M, Nakachi K, Ueno H, Ikeda M, Morizane C, Yoshino M. Furuse J, et al. Among authors: morizane c. Jpn J Clin Oncol. 2005 Dec;35(12):733-8. doi: 10.1093/jjco/hyi190. Epub 2005 Nov 22. Jpn J Clin Oncol. 2005. PMID: 16303793 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

242 results

Search Page

Filters